FDA Clearance Tracker · N970012-S197
AMS 700 Inflatable Penile Prosthesis (with and without InhibiZone)
Last checked: Nov 20, 2026Latest source record: Nov 14, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Nov 14, 2023
Approved
Time to decision
228 days
Received Mar 31, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- N970012-S197
- Device name
- AMS 700 Inflatable Penile Prosthesis (with and without InhibiZone)
- Applicant
- Boston Scientific Corp
- Applicant location
- Marlboro, MA
- Received
- Mar 31, 2023
- Decided
- Nov 14, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- N970012
Device type
- Device type
- Prosthesis, penis, inflatable (JCW)
- Device class
- Class III
- Regulation
- 21 CFR 876.3350
- Specialty
- GI, Urology & Nephrology
FDA's approval statement
As written in FDA's record.
Approval to commercialize a next generation pump design, the TENACIO Pump, for use in the AMS 700 Inflatable Penile Prosthesis (IPP).
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.